IDWeek Program


2023 Program-at-a-Glance

The IDWeek Program-at-a-Glance, is available! Here you can find session titles, affiliated event times, exhibit hall hours. Review the Program-at-a-Glance and prepare to register for IDWeek 2023!

Access the Interactive Program

The IDWeek 2023 Interactive Program is now live! Explore sessions, tracks and newly announced speakers with this user-friendly resource. With more than 120 symposia and sessions on trending ID subjects from COVID-19 to climate change to antimicrobial stewardship myth busters, this IDWeek is reimagining your ID experience.   

The Interactive Program has the latest information for IDWeek 2023. With over 150 sessions to choose from there’s so much to learn and explore! 

Registrants get IDWeek on demand access until March 31, 2024

Explore sessions, tracks and newly announced speakers with this user-friendly resource. With more than 120 symposia and sessions on trending ID subjects from COVID-19 to climate change to antimicrobial stewardship myth busters, this IDWeek is reimagining your ID experience.   

IDWeek 2021 Program information coming soon.


Claim your credits by April 24, 2024.

The deadline to claim credit is April 24, 2024. Attendees must attend each selected session in its entirety to receive CME/CNE/CPE/MOC credit. Partial credit is not available. To claim CPE in-person session credit the deadline is Dec. 12.

In support of improving patient care, IDSA is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

This activity was planned by, and for, the healthcare team, and learners will receive 207.5 Interprofessional Continuing Education (IPCE) credits for learning and change.

  • Update infectious diseases clinicians, investigators, infection preventionists, and pharmacists with state of- the-art developments in the field, including timely reviews of recent advances in clinical care and research, and original reports of clinical, translational, and basic research in infectious diseases and healthcare epidemiology.

  • Bridge the widening gaps among the fields of infectious diseases clinical practice and research, including clinical, epidemiological, health services, implementation, translational and basic research.

  • Promote multi-disciplinary dialogue and collaboration among clinicians, investigators and pharmacists, thus facilitating advances in the prevention, diagnosis and treatment of infectious diseases.

  • Provide training in skills that promote the Infectious Disease specialty, including medical education, leadership and advocacy for policies that impact infectious diseases practice and the healthcare team.
Continuing Medical Education

CME Accreditation Statement for Physicians

IDSA designates this other activity (live course, internet live and internet enduring material activity) for a maximum of 207.5 PRA Category 1 Credits™. The core IDWeek sessions are designated for 168.5 credit hours and premeeting workshops are an additional 39. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Continuing Nursing Education

A total of 205 ANCC contact hours will be available.  The core IDWeek sessions are designated for 166 credit hours and premeeting workshops are an additional 39.

Continuing Pharmacy Education

CPE Accreditation Statement for Pharmacists
The continuing education activity for pharmacists has been developed by the Infectious Diseases Society of America.  IDSA is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. ACPE Universal Activity Number JA0007082-0000-22-002-L01-P has been assigned to these knowledge-based sessions. Pharmacy CE will be offered for both live and on-demand sessions. This conference is acceptable for a maximum of 181.25 live CPE contact hours (18.13 CEUs), and a maximum of 181.25on-demand CPE contact hours (18.13CEUs) in states that recognize ACPE providers. The registration fee covers the cost of CE credits. CE Statements of Completion will be issued by the Infectious Diseases Society of America (IDSA) at the conclusion of the conference. Participants must complete an evaluation for each session they attended to receive pharmacy CE credit. The deadline for completing the evaluations for the live CE sessions is Dec. 12. IDSA will upload all IDWeek CPE credits to NABP CPE Monitor accounts within 30 days of completion for live CE sessions, and within 60 days of completion for on-demand sessions through April 24, 2024. 

Maintenance of Certification

Successful completion of this CME activity enables the participant to earn up to 207.5 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

IDWeek 2023 physician participation information will be shared with ABIM through ACCME PARS

IDSA, in accordance with Joint Accreditation requirements and ACCME’s new Standards for Integrity and Independence in Accredited Continuing Education, requires everyone who is in a position to control the content of an accredited educational activity to disclose all financial relationships with any ineligible companies (those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients). The ACCME defines financial relationships as financial relationships in any amount occurring within the past 24 months that exists between the person in control of content and an ineligible company.

Faculty are required to either disclose financial relationships (name of ineligible company and nature of relationship) and include a statement that all relevant financial relationships have been mitigated or indicate that there are no relevant financial relationships. Disclosure to learners must not include ineligible companies’ corporate or product logos, trade names, or product group messages.

IDSA is responsible for ensuring that all CE-accredited activities are fair and balanced, and any clinical content presented supports safe, effective patient care. IDSA must also ensure all decisions related to the planning, faculty selection, delivery, and evaluation of accredited education are free from commercial bias and made without any influence or involvement from the owners and employees of an ineligible company.

Session Types

Industry sponsored affiliated events include up to 2-hour satellite symposia, 1-hour presentation theaters, and 45-minutes learning lounges.

2023 Program Committee

headshot civ white coat

Heather Yun, MD, FIDSA

Brooke Army Medical Center
IDWeek Chair, IDSA

Belinda Ostrowsky, MD, MPH

CDC & Montefiore/Albert Einstein College of Medicine
IDWeek Chair, SHEA
Atlanta headshots by

Wendy Armstrong, MD, FIDSA, FACP

Emory University School of Medicine
IDWeek Chair, HIVMA

Natasha Halasa, MD, FIDSA, FPIDS

Vanderbilt University Medical Center
IDWeek Chair, PIDS

Premeeting Workshops

Thank you reviewers!

The IDWeek Program Committee would like to extend a special Thank You to the following individuals who generously donated their time and expertise to review abstracts for IDWeek 2023.

Want to volunteer to review IDWeek abstracts?

Ume Abbas, MD; University of Missouri at Kansas City

Maheen Abidi, MD; University of Colorado Denver

Paul Adjei, MD; Military

Rabia Agha, MD; Maimonides Children’s Hospital

Sharjeel Ahmad, MD; University of Illinois College of Medicine-Peoria

Ronda Akins, PharmD; Methodist Charlton Medical Center

Fritzie Albarillo, MD; Loyola University Medical Center

John Albin, MD; Massachusetts General Hospital

Bryan Alexander, PharmD; Nebraska Medicine

Majdi Al-Hasan, MD; University of South Carolina School of Medicine

Vanessa Allen, MD; Sinai Health and University Health Network

Jaffar Al-Tawfiq, MD; Johns Hopkins Aramco Healthcare

Rajalakshmi Ananthanarayanan, MD; Kerala Institute of Medical Sciences

Marsha Anderson, MD; University of Colorado School of Medicine

Michael Angarone, DO; Northwestern University

Shweta Anjan, MD; University of Miami

Brenda Anosike, MD; Children’s Hospital at Montefiore

Senu Apewokin, MD; University of Cincinnati

Sowminya Arikapudi, MD; Integris Baptist Medical Center

Naomi Aronson, MD; Uniformed Services University of the Health Sciences

Antonio Arrieta, MD; Children’s Hospital of Orange County

Aparna Arun, MD; Stanford University School of Medicine

Folusakin Ayoade, MD; University of Miami Miller School of Medicine

Skip to content